Hexima Ltd - Strategic SWOT Analysis Review

Hexima Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Hexima Ltd (Hexima) is a biotechnology company that researches, develops and commercializes plant-derived proteins and peptides for its applications as human therapeutics. The company utilizes its proprietary technologies such as plant defensin antifungal technology platform and peptide ligation technology for the development of products to find treatments for various fungal/infectious diseases. HXP124, its pipeline drug candidate is being developed for the treatment of fungal nail infections (onychomycosis). The companys operations are mainly in Australia. Hexima is headquartered in Melbourne, Victoria, Australia.

Hexima Ltd Key Recent Developments

May 21,2019: Hexima announces appointment of Michael Aldridge
Mar 12,2019: Hexima: Interim Consolidated Financial Report

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Section 1 - About the Company
Hexima Ltd - Key Facts
Hexima Ltd - Key Employees
Hexima Ltd - Key Employee Biographies
Hexima Ltd - Major Products and Services
Hexima Ltd - History
Hexima Ltd - Company Statement
Hexima Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Hexima Ltd - Business Description
Hexima Ltd - SWOT Analysis
SWOT Analysis - Overview
Hexima Ltd - Strengths
Hexima Ltd - Weaknesses
Hexima Ltd - Opportunities
Hexima Ltd - Threats
Hexima Ltd - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Hexima Ltd, Recent Deals Summary
Section 4 Companys Recent Developments
May 21, 2019: Hexima announces appointment of Michael Aldridge
Mar 12, 2019: Hexima: Interim Consolidated Financial Report
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Hexima Ltd, Key Facts
Hexima Ltd, Key Employees
Hexima Ltd, Key Employee Biographies
Hexima Ltd, Major Products and Services
Hexima Ltd, History
Hexima Ltd, Subsidiaries
Hexima Ltd, Key Competitors
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Hexima Ltd, Recent Deals Summary

List Of Figures


Hexima Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Hexima Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Hexima Ltd - Strategic SWOT Analysis Review

Hexima Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

TBG Diagnostics Ltd - Product Pipeline Analysis, 2021 Update

TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The companys major products include

USD 750 View Report

Huntleigh Healthcare Ltd - Product Pipeline Analysis, 2021 Update

Huntleigh Healthcare Ltd (Huntleigh Healthcare) is a medical device company. The company develops, manufactures and distributes electronic medical equipment. It offers vascular assessment and treatment; fetal and patient monitoring; and

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available